Skip to main content
Year archive

Heidelberg Pharma AG — 2013 filings

All 28 regulatory filings released by Heidelberg Pharma AG (HPHA) in 2013, sourced directly from the official regulator.

28 Filings
2013 Period
2013 filings (28)
Filing Released Lang
WILEX AG regains US rights for RENCAREX(R) from Prometheus
Legal Proceedings Report
2013-11-07 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements
2013-10-10 English
WILEX AG publishes 9-month Financial Report 2013
Earnings Release 9M 2013
2013-10-10 English
Q3 Report 2012/2013
Interim / Quarterly Report 9M 2013
2013-10-10 German
WILEX AG: Nuclea Biotechnologies Inc. acquires WILEX Inc. and extends their cooperation with WILEX AG
M&A Activity
2013-09-06 English
WILEX AG: Nuclea Biotechnologies Inc. acquires WILEX Inc. and extends their cooperation with WILEX AG
M&A Activity
2013-09-06 English
WILEX AG: WILEX subsidiary Heidelberg Pharma signs license agreement for the development of Antibody Targeted Amanitin Conjugates (ATACs) with Roche
Regulatory Filings
2013-09-02 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements
2013-08-09 English
WILEX AG starts clinical phase I trial with PI3K inhibitor WX-037
Regulatory Filings
2013-08-07 English
WILEX AG publishes half-yearly financial report 2013
Earnings Release H1 2013
2013-07-11 English
Q2 Report 2012/2013
Interim / Quarterly Report H2 2013
2013-07-11 German
WILEX AG: UCB gets access to rights for an antibody programme from WILEX for non-oncology indications
M&A Activity
2013-07-10 English
WILEX AG: Burrill Securities supports WILEX in exploring financing partners
Capital/Financing Update
2013-07-02 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements
2013-06-18 English
WILEX AG: Phase III ARISER data for the adjuvant treatment of clear cell renal cancer with RENCAREX(R) including retrospective subgroup analysis presented at ASCO
Regulatory Filings
2013-06-03 English
Wilex AG: Bekanntmachung der Einberufung zur Hauptversammlung am 14.06.2013 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2013-05-06 German
WILEX AG publishes 3-months financial report 2013
Earnings Release Q1 2013
2013-04-11 English
WILEX AG has been selected to give several presentations at ASCO
Regulatory Filings
2013-04-11 English
Q1 Report 2012/2013
Interim / Quarterly Report Q1 2013
2013-04-11 German
WILEX AG: WILEX Inc. and Nuclea Biotechnologies Inc. announce cooperation
M&A Activity
2013-03-20 English
DGAP-DD: WILEX AG english
Director's Dealing
2013-03-04 English
DGAP-DD: WILEX AG english
Director's Dealing
2013-03-04 English
WILEX AG: WILEX reports financial figures for financial year 2012
Earnings Release FY 2012
2013-02-27 English
Annual Financial Statements 2011/2012
Annual Report FY 2012
2013-02-27 German
WILEX AG: Further analysis of the ARISER study identifies a subgroup which shows significant improvement of disease-free survival with RENCAREX(R)
Legal Proceedings Report
2013-02-26 English
WILEX AG: WILEX Inc. and IBL-America sign non-exclusive marketing and distribution agreement for USA
Regulatory Filings
2013-01-31 English
WILEX AG: WILEX Inc. and GeneDiagnostics Inc. enter into partnership for the IVD approval and distribution of the serum HER-2/neu test in China
M&A Activity
2013-01-23 English
Report Publication Announcement 2013
Report Publication Announcement
2013-01-17 English